[1]BioorganicandMedicinalChemistryLetters,2005,vol.15,p.5039-5044
[2]Patent:US2005/119260,2005,A1.Locationinpatent:Page/Pagecolumn40
114873-08-4
1218-34-4
16305-75-2
16108-03-5
20762-32-7
57105-50-7
858124-35-3 | Methyl 4-bromo-3-formylbenzoate | AA00IDPI | MFCD16036866
862314-10-1 | Ethyl 5-amino-2-chloroisonicotinate | AA00IDW2 | MFCD20486145
866769-99-5 | 2,5-Bis(4-bromophenyl)-1,1-dimethyl-3,4-diphenylsilacyclopenta-2,4-diene | AA00IE3K | MFCD28384134
870300-76-8 | N-Boc-n-(phenylsulfonylmethyl)-hydroxyamine | AA00IE8Y | MFCD11707047
874299-06-6 | 1-Isopropyl-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea | AA00IEHW | MFCD22494304
878218-25-8 | 1-(4-Cyanophenyl)-N-isopropylmethanesulfonamide | AA00IEPP | MFCD08239623
883443-16-1 | 1-Bromo-3-propylsulfanylbenzene | AA00IEZ3 | MFCD20040719
885950-95-8 | 4-[3,5-Bis(trifluoromethyl)phenyl]benzenesulphonyl chloride | AA00IF5S | MFCD01631924
887344-39-0 | [2-(4-Fluorophenoxy)phenyl]sulfonyl chloride | AA00IFAZ | MFCD03840030
892293-07-1 | 3-(6,8-Dioxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinazolin-7(6h)-yl)propanoic acid | AA00IFJ0 | MFCD14726785